天然药物化学第二讲课件.ppt
- 【下载声明】
1. 本站全部试题类文档,若标题没写含答案,则无答案;标题注明含答案的文档,主观题也可能无答案。请谨慎下单,一旦售出,不予退换。
2. 本站全部PPT文档均不含视频和音频,PPT中出现的音频或视频标识(或文字)仅表示流程,实际无音频或视频文件。请谨慎下单,一旦售出,不予退换。
3. 本页资料《天然药物化学第二讲课件.ppt》由用户(晟晟文业)主动上传,其收益全归该用户。163文库仅提供信息存储空间,仅对该用户上传内容的表现方式做保护处理,对上传内容本身不做任何修改或编辑。 若此文所含内容侵犯了您的版权或隐私,请立即通知163文库(点击联系客服),我们立即给予删除!
4. 请根据预览情况,自愿下载本文。本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
5. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007及以上版本和PDF阅读器,压缩文件请下载最新的WinRAR软件解压。
- 配套讲稿:
如PPT文件的首页显示word图标,表示该PPT已包含配套word讲稿。双击word图标可打开word文档。
- 特殊限制:
部分文档作品中含有的国旗、国徽等图片,仅作为作品整体效果示例展示,禁止商用。设计者仅对作品中独创性部分享有著作权。
- 关 键 词:
- 天然 药物 化学 第二 讲课
- 资源描述:
-
1、Introduction to the Studies of Biosynthesis of Natural Products Yuemao SCollege of Pharmaceutical Sciences,Shandong UniversitySeptember 13,20103.Three examplesThe Biosynthesis of TaxolTechniques we applied:A.Stable isotope labeling,feedingB.Radioactive isotope tracing in Enzymatic acetylation Conclu
2、sion:10-deacetylbaccatin-III is a precursor of taxol02000400060008000CPM05101520Retention time,min Figure B-210g Of 10-deacetylbaccatin-III incubated with 1Ci of 3H-acetyl-CoA plus100nmole unlabeled acetyl-CoA and 300l of crude cell free extract fromTaxus media cell cultures collected on the 5th day
3、 and 7th day,respectively.300ul of boiled 7th days crude cell free extract300ul of 7th days crude cell-free extract300ul of boiled 5th days crude cell-free extract300ul of 5th dayscrude cell-free extractbaccatin-IIIHPLC conditions:Solvents:A.H2O;B.AcetonitrileFlow rate:1ml/minGradient:(T min,B%),(0,
4、40),(5,40),(15,70)UV detection at 230nmHypothetic multiple pathways towards taxolAcOOHOHAcOOOONHOHOOOBzAcOOHOHAcOOOHOOBzTaxolBaccatin-IIIHOOHOHAcOOOONHOHOOOBzHOOHOHAcOOOHO10-DeacetyltaxolOBz10-Deacetylbaccatin-IIIABABThe biosynthesis of rifamycin BTwo possible pathways,A and B,towards rifamycin B.A
5、demanded that protorifamycin I is the key intermediate and the oxygen at the C-8 position is introduced later.B required that the oxygen at C-8 is of the same origin as the carbon of C-8,i.e.,from the carboxyl group of AHBA.OHH3COOCH2CO2HNHOHOHOHCH3CH3OOCH3CH3CH3CH3CH3COOCH3OOOHNH2OOOH OH OH OHEnzSO
6、OHNHOHOHOHOHOOOOHOOHNHOHOHOHOHOOOOHOOHABrifamycin B 8x propionate 2x acetateprotorifamycin Iproansamycin Xrif PKSs888C.6HOONH2OHAHBA+Methods and Techiques:DNA mutagensis;stable isotope labeling,feeding;13C NMR assay;LC-ESI-MSConclusions:A.The C-8 oxygen is the same origin as the C-8 carbonB.The form
7、ation of naphthoquinone precedes the lactamizationC.The biosynthesis of type I polyketides occurs progressivelyThe sequence of the formation of the naphthoquinone and lactamEnz-SOHOHOHOHNH2OHOHOONH2OHOHOOtype I PKSsThe mutant HGF010,in which the genes from rifF to rifN and part of rifE were deleted.
8、Upon feeding AHBA,this mutant should produce C.15 or related compounds.rifArifBrifCrifDrifEC.15PEP+E4PrifG,rifH,rifI,rifK,rifL,rifM,rifNAHBA(3-amino-5-hydroxybenzoic acid)rifA,rifB,rifC,rifD,rifErifFOHOHOHOHNH2OHOHOONH2OHOHOOEnz-SOONH2HOOOHOHOHOHHOOtype I PKSsThe mutant HGF018,in which the rifF gene
9、 was deleted,thus it might accumulate C.10 or C.10a or related compounds.rifArifBrifCrifDrifEC.10PEP+E4PrifG,rifH,rifI,rifK,rifL,rifM,rifNAHBA(3-amino-5-hydroxybenzoic acid)rifA,rifB,rifC,rifD,rifEC.10arifFOONH2MeOMeOOOOHNH2OHOOHOOONH2HOHOOOSY5OHNHOHOOHOCHOOHNHOHOOHOCCH3OOONH2HOOOOHOOONH2HOOOHHOOOON
10、H2HOOOOHOHOHOOONH2HOOOHOHOHHOOOONH2HOHOOOOHOHOHOHSY4aSY4b16111517SY5SY41816111517123456789124356123456789124356123456789124356SY7SY618201111171919212421SY9SY822241111212323253027SY101324567891011131517192123252627282930313218The structures of new polyketides from the HGF018 mutant(Scheme C-10).C.16C
11、.17C.18C.19C.19C.20C.22C.21C.23C.25type I PKSsrifArifBrifCrifDrifEPEP+E4PrifG,rifH,rifI,rifK,rifL,rifM,rifNNH2OHOHOAHBA(3-amino-5-hydroxybenzoic acid)rifA,rifB,rifC,rifD,rifEOONH2HOOOHOHOHOHHOOC.27rifFOONH2HOOOHOHOHOHHOOC.26OHOONH2HOOOONH2HOOOHH+SY5-10The suspected conversion of the original compoun
12、ds produced by the HGF018 mutan to SY5-10 by dehydration during workup.C.28C.29Table 5 Ions selected in LC-ESI-MS analysis for the methanol extract of the HGF018 mutant.280b SY4 (Scheme C-12)298 P8/1-OG(Scheme C-11)320a SY4a (Scheme C-12)334a SY4b (Scheme C-12)344a SY5 (Scheme C-12)372 SY5a(Scheme C
13、-16)362 SY5b (Scheme C-17)390 SY5c (Scheme C-18)402a SY6 (Scheme C-12)430 SY6a (Scheme C-16)420 SY6b (Scheme C-17)448 SY6c (Scheme C-18)442a SY7 (Scheme C-12)470 SY7a (Scheme C-16)460c SY7b (Scheme C-17)SY7 (Scheme C-17)488 SY7c (Scheme C-18)518a SY8 (Scheme C-12)500b SY8 (Scheme C-17)546 SY8a (Sche
14、me C-16)536 SY8b (Scheme C-17)564 SY8c (Scheme C-18)558a SY9 (Scheme C-12)586 SY9a (Scheme C-16)576c SY9b (Scheme C-17)SY9 (Scheme C-17)604 SY9c (Scheme C-18)602a SY10 (Scheme C-12)630 SY10a (Scheme C-16)620 SY10b(Scheme C-17)648 SY10c (Scheme C-18)642 C.26 (Scheme C-13)670 C.26a (Scheme C-14)684 C.
15、26b (Scheme C-14)660 C.27 (Scheme C-13)688b SY11a(Scheme C-14)702 C.27b (Scheme C-14)662 C.28 (Scheme C-13)666 C.29 (Scheme C-13)650 C.30 (Scheme C-13)a.Detected by LC-ESI-MS in the HGF010 and HGF018 mutant,and isolated from the HGF018mutant.b.Only detected by LC-ESI-MS in the HGF018 mutant.c.Each h
16、as two candidate structures,SY7b and SY7,and SY9b and SY9,respctively.Accordingto the retention time of respective peak in HPLC,the two compounds detected in this experimentwere SY7 and SY9 rather than SY7b and SY9b.OHH3COOCH2CO2HNHOHOHOHCH3CH3OOCH3CH3CH3CH3CH3COOCH3OOOHNH2OOOHOHOHOHEnzSOOHNHOHOHOHO
17、HOOOOHOOHNHOHOHOHOHOOOOHOOHrifamycin B AHBA 8x propionate 2x acetateprotorifamycin Iproansamycin Xrif PKSs888C.6ABPathway B is correctOHH3COOCH2CO2HNHOHOHOHCH3CH3OOCH3CH3CH3CH3CH3COOCH3OORifamycin BThe rifamycin B biosynthetic pathway deduced from the chemical data obtained from the studies on the c
展开阅读全文